ロード中...
Management of Pulmonary Arterial Hypertension
PURPOSE OF REVIEW: This review focuses on the therapeutic management and individualized approach to Group 1 pulmonary arterial hypertension (PAH), utilizing Food and Drug Administration-approved PAH-specific therapies and various interventional and surgical options for PAH. RECENT FINDINGS: The para...
保存先:
| 出版年: | Curr Cardiovasc Risk Rep |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer US
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7671829/ https://ncbi.nlm.nih.gov/pubmed/33224405 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12170-020-00663-3 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|